Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma

Tumor Biology ◽  
2013 ◽  
Vol 34 (5) ◽  
pp. 2741-2746 ◽  
Author(s):  
Guan-Xian Liu ◽  
Xin Zhang ◽  
Su Li ◽  
Richard D. Koiiche ◽  
Jerry H. Sindsceii ◽  
...  
2010 ◽  
Vol 30 (9) ◽  
pp. 673-676 ◽  
Author(s):  
Bedia Agachan ◽  
Rukset Attar ◽  
Elif Isbilen ◽  
Hulya Yilmaz Aydogan ◽  
Seyma Sozen ◽  
...  

1997 ◽  
Vol 61 (3) ◽  
pp. 353-360 ◽  
Author(s):  
Ronald Godiska ◽  
David Chantry ◽  
Carol J. Raport ◽  
Vicki L. Schweickart ◽  
Hai Le Trong ◽  
...  

2015 ◽  
Vol 9 (5) ◽  
pp. 2085-2089
Author(s):  
KOO HAN YOO ◽  
DONG-GI LEE ◽  
KYU YEOUN WON ◽  
SUNG-JIG LIM ◽  
YONG-KOO PARK ◽  
...  

BMC Cancer ◽  
2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Anastasios Stofas ◽  
Georgia Levidou ◽  
Christina Piperi ◽  
Christos Adamopoulos ◽  
Georgia Dalagiorgou ◽  
...  

2006 ◽  
Vol 13 (1) ◽  
pp. 156-159 ◽  
Author(s):  
Michael Heesen ◽  
Rosemarijn Renckens ◽  
Alex F. de Vos ◽  
Dagmar Kunz ◽  
Tom van der Poll

ABSTRACT Upon injection of Escherichia coli lipopolysaccharide into human volunteers, the monocyte density of CC chemokine receptor 2 (CCR2) decreased. Minimal CCR2 density was observed 4 h after injection. Peak plasma concentrations of the CCR2 ligand monocyte chemotactic protein 1 and of tumor necrosis factor alpha were reached after 4 h and 2 h, respectively.


Sign in / Sign up

Export Citation Format

Share Document